Longitudinal ultrasound-based AI model predicts axillary lymph node response to neoadjuvant chemotherapy in breast cancer: a multicenter study

Cui, Li-Gang
DOI: https://doi.org/10.1007/s00330-024-10786-5
IF: 7.034
2024-05-11
European Radiology
Abstract:Developing a deep learning radiomics model from longitudinal breast ultrasound and sonographer's axillary ultrasound diagnosis for predicting axillary lymph node (ALN) response to neoadjuvant chemotherapy (NAC) in breast cancer.
radiology, nuclear medicine & medical imaging
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop a deep - learning radiomics model based on longitudinal breast ultrasound for predicting the response of axillary lymph nodes (ALN) in breast cancer patients after receiving neoadjuvant chemotherapy (NAC). Specifically, the research aims to: 1. **Develop the model**: Construct a deep - learning radiomics model that can extract features from the longitudinal ultrasound images of breast cancer patients. These features include tumor - derived radiomics features and deep - learning features. 2. **Predict ALN response**: Use the above - mentioned model to predict the axillary lymph node response in breast cancer patients after receiving neoadjuvant chemotherapy, thereby helping doctors to more accurately assess the treatment effect and formulate subsequent surgical strategies. 3. **Improve diagnostic accuracy**: By comparing the model with the visual diagnosis of sonographers, verify the performance of the model in predicting the axillary lymph node status and explore whether the model can enhance the diagnostic ability of sonographers. ### Research background Neoadjuvant chemotherapy (NAC) is increasingly used in breast cancer patients with clinically positive axillary lymph nodes (ALN). Accurate assessment of ALN response after NAC is crucial for optimizing postoperative axillary surgical strategies. Although traditional axillary lymph node dissection (ALND) is standard, it has certain risks, such as lymphedema and infection. Therefore, accurately predicting the ALN response to NAC can significantly reduce unnecessary axillary surgeries and their associated risks. ### Methods - **Data collection**: From November 2016 to December 2022, breast cancer patients who received NAC and subsequently underwent surgery were recruited from three centers. - **Feature extraction**: Extract tumor - derived radiomics features and deep - learning features from ultrasound images and select quantitative features by multiple methods. - **Model construction**: Use the random forest algorithm to construct two machine - learning models based on the features before and after NAC, and then integrate these data into a fusion model through the support vector machine (SVM). - **Performance evaluation**: Evaluate the performance of the fusion model through the receiver operating characteristic curve (AUC), decision - curve analysis and calibration curve, and compare it with the diagnosis results of sonographers. ### Results - **Model performance**: In the validation cohort, the AUC value of the fusion model is 0.899, which is significantly better than the model before NAC (AUC: 0.786, p < 0.001), the model after NAC (AUC: 0.853, p = 0.014), and the diagnosis of sonographers (AUC: 0.719, p < 0.001). - **Decision - curve analysis**: In the range of threshold probabilities from 0.02 to 0.98, the fusion model shows patient benefits. - **Diagnostic ability improvement**: The fusion model also improves the diagnostic ability of sonographers, and the accuracy rate is increased from 71.9% to 79.2%. ### Conclusions - **Model accuracy**: The deep - learning radiomics model can accurately predict the ALN response in breast cancer patients after receiving NAC. - **Clinical application**: This model can assist sonographers to more accurately assess the ALN status before surgery and is helpful for making surgical decisions. ### Clinical significance The AI model based on ultrasound before and after NAC can accurately predict axillary lymph node metastasis and assist sonographers in axillary diagnosis.